Skip to content

Clinical trials

Leukemia, Biphenotypic, Acute trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Biphenotypic, Acute Country / region: Australia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20081
20172
20192
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting5
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group7
National Cancer Institute (NCI)1
National Institutes of Health Clinical Center (CC)1
PedAL BCU, LLC1
Princess Maxima Center for Pediatric Oncology1
Senti Biosciences1
Syndax Pharmaceuticals1
Therapeutic Advances in Childhood Leukemia Consortium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Biphenotypic, Acute14
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Leukemia4
Leukemia, Myeloid, Acute4
Burkitt Lymphoma3
Leukemia, Myelomonocytic, Juvenile3
Blastic Plasmacytoid Dendritic Cell Neoplasm2
Myelodysplastic Syndromes2
Blast Crisis1
Hematologic Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.